Did You Know?

Editor’s Picks

Latest News

MDCE Subsidiaries Execute First Fanatics / Topps Transaction: Infinite Auctions Sells, Real Game Used Authenticates (OTCID:MDCE)

Subsidiaries Positioned to Supply and Authenticate Products for One of the World's Largest Sports Collectibles Platforms MESA, AZ / ACCESS...

Rhelion Life Sciences’ Wholly Owned Subsidiary Filament Health to Deliver Oral Comments at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs

Sarit Hashkes, President of Filament Health Corp., will provide oral remarks at the United States Food and Drug Administration public...

Veteran Health Tech Leader Jim Longley Joins the Outcomes4Me Executive Team to Accelerate Growth and Support Mission of Empowering Patients with Cancer

After scaling revenue at OpenEvidence, GoodRx, and Doximity, Longley steps into the role of Chief Revenue Officer at Outcomes4Me to...

Ensysce Biosciences’ Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs

SAN DIEGO, CA / ACCESS Newswire / September 14, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company") a...

Phio Announces Key Development Milestone for PH-762 with FDA Submission Supporting Next Stage of Clinical Development in Cutaneous Squamous Cell Carcinoma

Company Proposes Planned Phase 2b Neoadjuvant Study Following Successful Completion of Phase 1b TrialKing of Prussia, Pennsylvania--(Newsfile Corp. - September...

BetterLife Pharma Inc. Announces Filing of Final Prospectus for US$100 Million Public Offering of Common Shares and Pre-Funded Warrants

FINAL PROSPECTUS ACCESSIBLE ON SEDAR+Vancouver, British Columbia--(Newsfile Corp. - September 11, 2026) - BetterLife Pharma Inc. (CSE: BETR) ("BetterLife" or...

error: Content is protected !!